The saccular stage is a period of fetal lung development characterized by formation and expansion of terminal sacs, thinning of the respiratory epithelium, close approximation of pulmonary capillaries, and increasing surfactant production.
The saccular stage is a period of lung development during which the distal respiratory passages expand to form numerous terminal sacs, also called primitive alveoli. At the same time, the respiratory epithelium becomes progressively thinner, pulmonary capillaries become closely associated with the developing air spaces, and surfactant production increases.
These changes substantially improve the structural capacity of the fetal lungs for gas exchange. The saccular stage therefore represents an important transition between the canalicular stage, when the first potential for gas exchange emerges, and the alveolar stage, during which mature alveoli progressively develop and multiply.
The saccular stage begins approximately around the 24th week of fetal development and continues until near birth, although the exact timing varies among embryology references and overlaps with adjacent developmental stages.
During this period, distal respiratory structures undergo rapid expansion and maturation in preparation for pulmonary respiration after birth.
The stages represent a continuous developmental process and overlap rather than occurring as sharply separated periods.
During the preceding canalicular stage, terminal bronchioles give rise to respiratory bronchioles, distal respiratory passages enlarge, pulmonary capillaries proliferate, and the respiratory epithelium begins differentiating into specialized cell types.
During the saccular stage, these processes advance considerably. Distal passages expand into terminal sacs, the epithelial lining becomes thinner, and capillaries become increasingly closely applied to the respiratory surface.
The defining anatomical feature of the saccular stage is the development of numerous terminal sacs, also called saccules.
These thin-walled distal spaces develop from the terminal portions of the respiratory passages and represent precursors of the mature alveolar structures involved in pulmonary gas exchange.
Terminal sacs progressively enlarge and increase the potential respiratory surface area of the developing lungs.
The expansion of these spaces occurs together with thinning of the surrounding interstitial tissue, allowing air and pulmonary capillary blood to become separated by progressively smaller diffusion distances.
The mesenchymal tissue separating the developing respiratory spaces and pulmonary capillaries becomes progressively thinner during the saccular stage.
This reduction in tissue thickness is essential for establishing an efficient interface across which oxygen and carbon dioxide can eventually diffuse.
The epithelial lining of the distal respiratory spaces differentiates into specialized type I pneumocytes and type II pneumocytes.
These cell populations perform different but complementary functions in the mature lung.
Type I pneumocytes differentiate into extremely thin squamous epithelial cells.
Their flattened morphology allows them to form much of the future gas-exchanging surface and minimizes the diffusion distance between air within the respiratory spaces and blood within pulmonary capillaries.
Type II pneumocytes remain more cuboidal and are responsible for synthesis and secretion of pulmonary surfactant.
They also serve as progenitor cells capable of proliferating and contributing to renewal of the alveolar epithelial lining.
Pulmonary surfactant is a surface-active material secreted primarily by type II pneumocytes.
It reduces surface tension at the air-liquid interface within the developing respiratory spaces and becomes essential for preventing widespread collapse of the lungs after air breathing begins.
Surfactant production begins before the saccular stage but increases substantially as fetal lung development progresses.
The increasing quantity and functional effectiveness of surfactant are major factors in the improving respiratory capacity of premature infants with advancing gestational age.
Type II pneumocytes package surfactant components within intracellular structures known as lamellar bodies.
These structures participate in storage and secretion of surfactant onto the luminal surface of the developing respiratory spaces.
The pulmonary capillary network continues to proliferate extensively during the saccular stage.
Capillaries become closely associated with the thin epithelial lining of the terminal sacs, producing the anatomical arrangement necessary for efficient pulmonary gas exchange.
As interstitial tissue becomes thinner, pulmonary capillaries move into increasingly close proximity to type I pneumocytes.
The basement membranes associated with the epithelial and endothelial layers become closely apposed and may fuse in regions of the developing gas-exchange surface.
The blood-air barrier, also called the alveolar-capillary barrier, becomes increasingly specialized during the saccular stage.
Its thin structure allows gases to diffuse between the future alveolar air spaces and blood circulating through pulmonary capillaries.
Progressive thinning of these components improves the efficiency of diffusion across the respiratory surface.
Expansion of terminal sacs, epithelial thinning, capillary proliferation, and increasing surfactant production collectively improve the ability of the developing lungs to support gas exchange.
Unlike the lungs during the pseudoglandular stage, lungs in the saccular stage possess increasingly developed structural components required for extrauterine respiration.
Terminal sacs are not identical to mature adult alveoli. They are relatively simple distal air spaces that subsequently undergo remodeling and subdivision.
During later development, secondary septa subdivide these spaces and contribute to the formation of increasing numbers of smaller, more mature alveoli.
The walls separating adjacent terminal sacs form the initial framework of the developing gas-exchange region.
These relatively thick partitions contain connective tissue and capillary networks that are subsequently remodeled during alveolar development.
As development proceeds into the alveolar stage, the terminal saccules undergo increasing subdivision through formation of secondary septa.
This process greatly increases the number of individual gas-exchanging units and expands the total respiratory surface area.
Secondary septa project into existing distal air spaces and subdivide them into smaller compartments.
This septation process is fundamental to alveolarization and continues extensively after birth.
| Feature | Canalicular Stage | Saccular Stage |
|---|---|---|
| Distal structures | Respiratory bronchioles and developing alveolar ducts | Numerous terminal sacs |
| Respiratory epithelium | Differentiation becomes evident | Marked thinning and specialization |
| Capillaries | Rapid proliferation and increasing proximity | Closely applied to terminal sac epithelium |
| Surfactant | Production begins and increases | Production becomes progressively greater |
| Gas-exchange capacity | Limited potential emerges | Substantially improved |
| Feature | Saccular Stage | Alveolar Stage |
|---|---|---|
| Dominant distal structure | Terminal sacs | Increasing numbers of alveoli |
| Major process | Sac expansion and epithelial thinning | Secondary septation and alveolar multiplication |
| Respiratory surface | Increasing rapidly | Expands dramatically |
| Postnatal continuation | Primarily prenatal | Continues extensively after birth |
The structural changes occurring during the saccular stage are essential preparation for the transition from placental gas exchange to pulmonary gas exchange at birth.
For successful air breathing, the lungs must contain sufficiently developed respiratory surfaces, an adequate pulmonary capillary network, and enough surfactant to maintain expansion of the distal air spaces.
At birth, fetal lung fluid is cleared from the respiratory spaces and the lungs expand with air.
Pulmonary vascular resistance falls as pulmonary blood flow increases, allowing the newly expanded respiratory surfaces to participate in gas exchange.
Surfactant becomes especially important when the lungs expand with air.
By lowering surface tension, surfactant reduces the tendency of small respiratory spaces to collapse and decreases the work required to expand the lungs during breathing.
Infants born during the saccular stage may survive because the lungs possess developing terminal sacs, pulmonary capillary networks, and some capacity for surfactant production.
However, the degree of respiratory maturity varies considerably with gestational age, and very premature infants may require substantial respiratory support.
Insufficient pulmonary surfactant is an important cause of neonatal respiratory distress syndrome in premature infants.
High surface tension promotes collapse of distal respiratory spaces, reducing pulmonary compliance and impairing gas exchange.
When premature delivery is anticipated, antenatal corticosteroids may be administered clinically to accelerate aspects of fetal lung maturation.
Among their important effects is promotion of surfactant-related maturation, which can reduce the risk and severity of respiratory complications associated with prematurity.
Premature newborns with inadequate endogenous surfactant may receive exogenous surfactant as part of neonatal respiratory management.
This therapy supplements the immature surfactant system and can improve pulmonary mechanics and gas exchange.
Pulmonary hypoplasia is characterized by inadequate development of lung tissue, airways, respiratory spaces, or pulmonary vessels.
Disturbances that restrict fetal lung growth can reduce the number and development of terminal respiratory structures and compromise postnatal respiratory function.
Development of terminal sacs alone is insufficient for effective respiration. Each gas-exchanging surface must be closely associated with an adequate pulmonary capillary supply.
The coordinated maturation of distal air spaces and pulmonary vessels is therefore a central feature of the saccular stage.
Lung development is not complete at birth. Alveolar formation and maturation continue extensively during infancy and childhood.
Postnatal alveolarization greatly increases the number and total surface area of gas-exchanging units compared with those present around the time of birth.
The saccular stage is a critical period of pulmonary maturation because the distal lung begins to acquire an increasingly effective gas-exchanging architecture. Terminal sacs expand, type I pneumocytes form thin respiratory surfaces, type II pneumocytes produce increasing amounts of surfactant, and pulmonary capillaries become closely applied to the developing epithelium.
These changes explain why respiratory survival becomes progressively more feasible with advancing gestational age. Premature birth can interrupt this maturation, leaving the infant with fewer developed respiratory spaces, an immature pulmonary vascular bed, and inadequate surfactant.
Understanding the saccular stage provides the developmental foundation for studying terminal sacs, pneumocyte differentiation, pulmonary surfactant, the blood-air barrier, pulmonary capillary maturation, premature lung development, neonatal respiratory distress syndrome, and subsequent alveolarization.